HHTM interviews the team behind AudioCardio, a mobile app that is said to offer a "data and science backed sound therapy ...
Hearing loss solutions are expensive and have a negative social stigma
Hearing aids cost between $2,000 and $8,000 per pair in the United States are rarely covered by insurance premiums. They also require a visit to a specialist, ongoing maintenance costs, and are often perceived as a disability.
Due to this, the average person waits over nine years before seeking professional help and less than 15% of people who could benefit from a hearing aid actually own one.
In many developing nations, it is extremely difficult to access hearing health professionals, quality care, adequate and affordable solutions.
Hearing loss is the third most common chronic condition in the world. And this problem is only being exacerbated by the growth of personal devices and our noisy environments. According to the World Health Organization, individuals with disabling hearing loss will accelerate and double to more than 900 million people by 2050.
Untreated hearing loss has also been associated with secondary physical and mental health issues that include isolation, increased risk of falling, developing depression, and dementia.
Personalized sound therapies designed to maintain and strengthen your hearing
Using data- and science- backed Threshold Sound Conditioning technology, AudioCardio users assess their hearing to generate personalized barely audible sound therapies to maintain and strengthen their hearing.
AudioCardio’s sound therapies don’t require active engagement. They work passively in the background while you do other activities like listening to music, exercising, working at your desk and falling asleep.
AudioCardio provides a comprehensive recovery program
Download the app from the Apple App or Google Play Stores. AudioCardio will then guide users through an initial assessment to measure baseline levels, generate personalized sound therapies and track progress as you use the app.
Backed by data and science
AudioCardio’s technology has been clinically proven in a double-blind randomized controlled trial conducted with Stanford University and Palo Alto Medical Foundation. 78% of the participants had more than a 10 decibel change in their hearing for the frequencies that were targeted.
24,000+ users and 2,700+ customers
135,000+ sound therapy sessions and 62,000+ hearing assessments
Grew web traffic by 35x in 12 months
46.1% ROI on performance marketing
Centre for Aging and Brain Health Innovation Award 2020
Completed Participation in Grid110 and Startup Boost accelerators
Participating in the Consortium for Technology & Innovation in Pediatrics, supported by Children's Hospital of Los Angeles, University of Southern California and a consortium of pediatric and research focused organizations (Seattle Children's Hospital, Oregon Health and Science University, UCLA, UC Berkeley, The Lundquist Institute, Larta Institute and more.)
4.7/5 stars for our effective, accessible, and easy solution
AudioCardio was created for the 460M+ people suffering from disabling hearing loss. AudioCardio is intended for individuals looking to strengthen their hearing or maintain their current state. We’ve received rave reviews for our platform’s effectiveness and ease of use.
D2C and B2B2C sales
AudioCardio employs a 'freemium' subscription model. Our app is free to download and use for 14-days with additional in-app purchases. Customers pay subscription fees ranging from $12.99 to $99.99. We are targeting the insurance, senior care, consumer electronics, and military defense industries along with apps like Calm, Spotify, and more for our B2B2C sales, royalties & licensing opportunities.
- Customer Lifetime Value: $48.56
- Customer Acquisition Cost: $17.70
*As of December 31, 2020
$19B+ addressable market
Our target market demographic is the 188M+ people who own a smartphone and have sensorineural hearing loss. With our current traction and the vast market need, we have projected a $19B TAM, with a beginning SOM of $760M in the U.S alone.
AudioCardio is a unique approach to hearing wellness
AudioCardio was created to fill the gap left by lack of innovation, expensive hearing aids, surgery, and inadequate hearing solutions. Unlike traditional solutions in the market, AudioCardio is affordable, accessible, and removes the negative social stigma to help you communicate better.
First line of hearing defense and complementary solution for hearing aids
Our vision is to improve the quality of life for the millions of people suffering from hearing loss and the secondary physical and mental health issues associated with untreated hearing loss. With your investment, AudioCardio will expand our brand recognition, partner with hospitals, medical centers, organizations and communities within our target demographics while establishing ourselves as the leading name in hearing health and wellness.
Raising to support a fully scaled marketing campaign
AudioCardio was bootstrapped during the first two years of operation and has since raised $350,000 in SAFE agreements. This previous investment allowed us to find early product market fit through 450+ customer discussion and interviews. We receive non-dilutive funding from organizations such as CTIP, granted through the support of the FDA.
Funds from our Republic raise will support a fully scaled marketing campaign, key hires, platform development and bringing on new partnerships, key industries and organizations across the United States and other key regions. This first round of crowdfunding will also allow us to pursue additional non-dilutive funding from government and non-profit organizations such as the National Institutes of Health, Department of Defense, Hearing Loss Association of America and more...
Removing barriers to care and erasing the stigma around hearing loss
We started AudioCardio with the mission to develop and provide an easily accessible and affordable solution for people with hearing difficulties.
In the summer of 2016, Chris wanted to take his grandfather on one last trip where he would be physically able to walk, fish and get around all on his own. During this trip, Chris realized that his grandfather’s memory loss was much more than simple forgetfulness. He was showing serious signs of accelerating cognitive decline.
Cofounder Chris Ellis (right) and his grandfather
Immediately after this trip, Chris started educating himself on cognitive decline, dementia and Alzheimer’s. During this self education, he came across a Johns Hopkins study that showed an association between untreated hearing loss and dementia, along with other studies associating isolation and depression.
Although his grandfather knew he had hearing loss and tinnitus, he refused to purchase hearing aids. The lack of convenient access to a specialist, cost of hearing aids, and negative social stigma all contributed to his distaste for the options on the market.
Serendipitously, Chris met Sam Kwak, a scientist and inventor from South Korea, around the same time this was all happening. Sam was working on a technology in hopes of helping people with hearing difficulties. After many conversations and meetings, the two decided to cofound AudioCardio in hopes of providing an easily accessible and affordable solution.